Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer

Emily Van Seventer, J. Peter Marquardt, Amelie S. Troschel, Till D. Best, Nora Horick, Chinenye C. Azoba, Richard Newcomb, Eric Roeland, Michael H. Rosenthal, Christopher P. Bridge, Joseph A. Greer, Areej El‐Jawahri, Jennifer S. Temel, Florian J. Fintelmann, Ryan David NippJournal of the National Comprehensive Cancer Network 2021 · DOI

Abstract

Although muscle mass (quantity) only correlated with survival, we found that muscle radiodensity (quality) was associated with patients' symptoms, healthcare use, and survival. These findings underscore the added importance of assessing muscle quality when seeking to address adverse muscle changes in oncology.
BibTeX
@article{seventer2021associations,
  author = {Emily Van Seventer and J. Peter Marquardt and Amelie S. Troschel and Till D. Best and Nora Horick and Chinenye C. Azoba and Richard Newcomb and Eric Roeland and Michael H. Rosenthal and Christopher P. Bridge and Joseph A. Greer and Areej El‐Jawahri and Jennifer S. Temel and Florian J. Fintelmann and Ryan David Nipp},
  title = {{Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer}},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2021},
  doi = {10.6004/jnccn.2020.7618},
}

Loading related content...

Figure